[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525128":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":30,"responsibleParty":48,"collaborators":20,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":20,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":20,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":69,"overallStatus":72,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"I-STAMP Testing","EXPERIMENTAL","Study procedures will be conducted as follows:\n\nActivities 1-3: Data Collection for application development\n\nActivity 4: To be added with future amendment",[13],"Behavioral: I-STAMP",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","I-STAMP","A patient-facing smartphone application that hosts participants' analgesic and laxative medications, provides pain-specific psychoeducation, collects patient reported outcomes, and provides feedback to participant symptoms.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Andrea Enzinger, MD","PRINCIPAL_INVESTIGATOR",[26],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","617-582-7335","Andrea_Enzinger@dfci.harvard.edu",[31],{"facility":32,"status":20,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Dana Farber Cancer Institute","Boston","Massachusetts","02215","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-71.05977,42.35843,{"lat":42,"lon":41},[45,47],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":46},"andrea_enzinger@dfci.harvard.edu",{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":24,"investigatorFullName":23,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Principal Investigator","100525128","integrated-smartphone-technology-to-alleviate-malignant-pain-i-stamp-testing-100525128",false,"NCT06117709","Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing","Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP): Development, Usability, and Acceptability Testing","Inclusion Criteria for Participants (Activities 1a, 2a, 3a):\n\n* Age ≥ 21 years\n* Current or previous diagnosis of advanced cancer\n* Current or previous experience with cancer pain\n\nExclusion Criteria for Participants (Activities 1a, 2a, 3a):\n\n* Inability to understand, speak, or read English\n* Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.","ALL","21 Years",{"count":60,"type":61},73,"ESTIMATED","INTERVENTIONAL",[64],"NA","The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.",[67,68],"Advanced Cancer","Pain",[67,70,71],"Pain management","Opioid pain management","NOT_YET_RECRUITING","2026-07-15",{"date":75,"type":76},"2026-07-16","ACTUAL",{"date":78,"type":61},"2026-08",{"date":80,"type":61},"2026-11-30",{"name":5,"class":6},1]